Deputy Mayor Kit Malthouse visits LBIC offering £160 million funds for Life Science investment, equipment and facilities to London Biotech companies

London Bioscience Innovation Centre’s Spring 2013 newsletter featuring Keith Powell Chairman of Domainex and his Biotech growth plan in collaboration with Mayor Boris Johnson’s Science and Technology Panel

Domainex announces investment round to progress its TBK1/IKKe and epigenetic programmes

Cambridge Research Biochemicals adds QuickAllAssay™ Lanthanide labelling reagents to its product range

Domainex Launches Discovery STAR Award to Support Translational Research in Early Academic Drug Discovery

Domainex announces that compounds from its IKKepsilon programme have activity against the IL-17 signaling pathway; opening up opportunities in autoimmune disease treatment.

Phase 3 clinical trial begins in early form of dementia following earlier study with promising results in mild to moderate Alzheimer’s patients.

AssayMetrics and Cambridge Research Biochemicals collaborate in the field of Fluorescence Lifetime technology

Edenhouse Solutions acquires Manchester-based Maven to expand its SAP business